← Leaderboards
Alexander Georg Marneros
Massachusetts General Hospital
$9,499,330
Attributed
$9,499,330
Total exposure
8
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.3M · FY2008–25$2M$1.5M$1M$500K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$9,499,330 · 8
By mechanism
R01$8,215,213 · 5
R21$1,284,117 · 3
Top collaborators
No co-investigators on record.
Most similar at Massachusetts General Hospital
Same institution · by research overlap
- Harald W. Jueppner$19,159,604
- Murat Bastepe$9,215,842
- Benjamin James Vakoc$7,888,946
- Michael Mannstadt$4,555,232
- David E Fisher$28,420,496
Others in their field
Top investigators on “Molecular”
- David Heimbrook · Leidos Biomedical Research, Inc.$871,088,761
- Leonard Freedman · Leidos Biomedical Research, Inc.$468,573,385
- Richard Webby · St. Jude Children'S Research Hospital$254,843,170
- Larry Arthur$238,531,074
- Gregory H Reaman · National Childhood Cancer Foundation$230,630,913
- Ralph Parchment · Leidos Biomedical Research, Inc.$193,231,914
Research focus
MolecularSignal TransductionAffectCellsMediatingIn VivoExperimental StudyPreventMouse ModelTherapeutic TargetPathogenesisImpairmentPathway InteractionsIn VitroExudative Age-Related Macular DegenerationPostnatalBaseClinically RelevantLesionGeneticMacrophageInhibitor/AntagonistChoroidal NeovascularizationLasers
Grant awards (28)
Cellular and molecular mechanisms of AIM2 and NLRP3 inflammasome activation in age-related macular degeneration$512,164
R01 · FY2025 · EY · contact PI
Proangiogenic M2-type macrophages and choroidal neovascularization$377,234
R01 · FY2025 · EY · contact PI
Cellular and molecular mechanisms of AIM2 and NLRP3 inflammasome activation in age-related macular degeneration$483,730
R01 · FY2024 · EY · contact PI
Proangiogenic M2-type macrophages and choroidal neovascularization$454,331
R01 · FY2024 · EY · contact PI
Cellular and molecular mechanisms of AIM2 and NLRP3 inflammasome activation in age-related macular degeneration$490,506
R01 · FY2023 · EY · contact PI
Proangiogenic M2-type macrophages and choroidal neovascularization$423,758
R01 · FY2023 · EY · contact PI
Functional characterization of a novel key regulator of the distal nephron whose deficiency leads to renal fibrosis and cyst formation$349,872
R01 · FY2023 · DK · contact PI
Proangiogenic M2-type macrophages and choroidal neovascularization$423,758
R01 · FY2022 · EY · contact PI
Mechanisms controlling distal nephron maturation$354,768
R01 · FY2022 · DK · contact PI
Functional characterization of a novel key regulator of the distal nephron whose deficiency leads to renal fibrosis and cyst formation$349,872
R01 · FY2022 · DK · contact PI
Mechanisms controlling distal nephron maturation$354,768
R01 · FY2021 · DK · contact PI
Functional characterization of a novel key regulator of the distal nephron whose deficiency leads to renal fibrosis and cyst formation$349,872
R01 · FY2021 · DK · contact PI
Mechanisms controlling distal nephron maturation$354,768
R01 · FY2020 · DK · contact PI
Functional characterization of a novel key regulator of the distal nephron whose deficiency leads to renal fibrosis and cyst formation$349,872
R01 · FY2020 · DK · contact PI
Role of KCTD1 for primary hyperparathyroidism$197,094
R21 · FY2020 · AG · contact PI
Mechanisms controlling distal nephron maturation$354,768
R01 · FY2019 · DK · contact PI
Functional characterization of a novel key regulator of the distal nephron whose deficiency leads to renal fibrosis and cyst formation$349,872
R01 · FY2019 · DK · contact PI
Role of KCTD1 for primary hyperparathyroidism$239,094
R21 · FY2019 · AG · contact PI
Identification of key cellular mechanisms that instruct macrophage polarization and therapeutic applications of specific inhibition of M2-type macrophage polarization$184,622
R21 · FY2019 · AI · contact PI
Identification of key cellular mechanisms that instruct macrophage polarization and therapeutic applications of specific inhibition of M2-type macrophage polarization$226,747
R21 · FY2018 · AI · contact PI
Innate Immunity and NLRP3 inflammasome activation in pathologic neovascularization$196,905
R21 · FY2017 · EY · contact PI
Innate Immunity and NLRP3 inflammasome activation in pathologic neovascularization$239,655
R21 · FY2016 · EY · contact PI
Molecular mechanisms of choroidal neovascularization and vascular homeostasis$420,552
R01 · FY2011 · EY · contact PI
Molecular mechanisms of choroidal neovascularization and vascular homeostasis$157,671
R01 · FY2011 · EY · contact PI
Molecular mechanisms of choroidal neovascularization and vascular homeostasis$438,075
R01 · FY2010 · EY · contact PI
Molecular mechanisms of choroidal neovascularization and vascular homeostasis$442,292
R01 · FY2009 · EY · contact PI
Molecular mechanisms of choroidal neovascularization and vascular homeostasis$304,200
R01 · FY2008 · EY · contact PI
Molecular mechanisms of choroidal neovascularization and vascular homeostasis$118,510
R01 · FY2008 · EY · contact PI